2. Academic Validation
  3. An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the Bunyavirales Order

An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the Bunyavirales Order

  • ACS Med Chem Lett. 2023 Mar 30;14(4):506-513. doi: 10.1021/acsmedchemlett.3c00048.
Kevin J Sparrow 1,  Rinu Shrestha 1 2,  James M Wood 1 2,  Keith Clinch 1,  Brett L Hurst 3,  Hong Wang 3,  Brian B Gowen 3,  Justin G Julander 3,  E Bart Tarbet 3,  Alice M McSweeney 4,  Vernon K Ward 4 2,  Gary B Evans 1 2,  Lawrence D Harris 1 2
Affiliations

Affiliations

  • 1 Ferrier Research Institute, Victoria University of Wellington, 69 Gracefield Road, Lower Hutt 5040, New Zealand.
  • 2 The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1142, New Zealand.
  • 3 Institute for Antiviral Research, Utah State University, Logan, Utah 84322-5600, United States.
  • 4 Department of Microbiology & Immunology, University of Otago, PO Box 56, Dunedin 9054, New Zealand.
PMID: 37077387 DOI: 10.1021/acsmedchemlett.3c00048
Abstract

We report for the first time the Antiviral activities of two iminovirs (Antiviral imino-C-nucleosides) 1 and 2, structurally related to galidesivir (Immucillin A, BCX4430). An iminovir containing the 4-aminopyrrolo[2,1-f][1,2,4-triazine] nucleobase found in remdesivir exhibited submicromolar inhibition of multiple strains of influenza A and B viruses, as well as members of the Bunyavirales order. We also report the first syntheses of ProTide prodrugs of iminovir monophosphates, which unexpectedly displayed poorer viral inhibition than their parent nucleosides in vitro. An efficient synthesis of the 4-aminopyrrolo[2,1-f][1,2,4-triazine]-containing iminovir 2 was developed to enable preliminary in vivo studies, wherein it displayed significant toxicity in BALB/c mice and limited protection against influenza. Further modification of this anti-influenza iminovir will therefore be required to improve its therapeutic value.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z